1,203 followers
Does 2013 GOLD class. improve ability to predict lung function decline, exacerbations & mortality: the UPLIFT trial http://t.co/IdTo0sy2uw
Does 2013 GOLD class. improve ability to predict lung function decline, exacerbations & mortality: the UPLIFT trial http://t.co/IdTo0sy2uw
@BioMedCentral GOLD ABCD worse at predicting mortality/function decline, better exacerbations in #COPD. http://t.co/Rq0tUvPKA1 #RespEd
@BioMedCentral GOLD ABCD worse at predicting mortality/function decline, better exacerbations in #COPD. http://t.co/Rq0tUvPKA1 #RespEd